Results 141 to 150 of about 76,320 (330)

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont, Vanessa Bloch, Agnès Lillo‐Lelouet, Christine Le Beller, Pierre A. Geoffroy, Marc Veyrier   +5 more
wiley   +1 more source

Effects of Naloxone on Circulation and Respiration during General Anesthesia [PDF]

, 1979
Bong Ill Kim, Soo Han Choi, Jin Woong Park   +2 more
openalex   +1 more source

Sleep Related Movement Disorders: What's New and Changing Clinical Practice

Journal of Sleep Research, EarlyView.
ABSTRACT Restless legs syndrome (RLS) is a common sensorimotor disorder, and the most common sleep‐related movement disorder with a prevalence of up to 15% in the European and US population. This review addresses key aspects of RLS, focusing on novel data that have or will likely have an impact on clinical practice.
Ambra Stefani, Qi Tang, Stefan Clemens, Lourdes M. DelRosso, Diego Garcia‐Borreguero, Raffaele Ferri, Birgit Frauscher, Evi Holzknecht, Federica Provini, Barbara Schormair, John Winkelman, Birgit Högl   +11 more
wiley   +1 more source

Engagement in a National Naloxone Programme among people who inject drugs [PDF]

, 2016
Bird, Sheila M., Goldberg, David, Hutchinson, Sharon J., McAuley, Andrew, Munro, Alison, Taylor, Avril   +5 more
core   +2 more sources

Antidote Stocking at Hospitals in North Palestine [PDF]

, 2007
Objective: The purpose of this study was to determine the availability and adequacy of antidote stocking at hospitals in north Palestine based on published guidelines for antidote stocking.
Al-Jabi W, Samah, Sawalha F, Ansam, Sweileh M, Waleed, Zyoud H, Sa'ed   +3 more
core   +1 more source

Naloxone Does Not Antagonize General Anesthesia in the Rat

, 1978
Marilyn H. Harper, P. Winter, Brynte H. Johnson, Edmond I. Eger   +3 more
openalex   +1 more source

Consensus on the Management of Anesthetic Agents During Digestive Motility Measurements and Proposal of a Standardized Protocol for Anesthesia (French Neuro Gastroenterology Group GFNG and Committee of Anesthetic French Experts)

Neurogastroenterology &Motility, EarlyView.
Anesthesia can alter measurements during digestive endoscopies, yet no standardized protocol currently exists. Two expert groups—the French Neuro‐Gastroenterology Group (GFNG) and anesthesiologists—used the Delphi method to reach a consensus on which drugs have an influence (91 amendments), ultimately resulting in a proposed anesthesia protocol (28 ...
Domitille Renard, Thomas Clavier, Osama Abou‐Arab, Gérard Amarenco, Emmanuel Besnier, Alice Blet, Matthieu Boisson, Charlène Brochard, Benoit Coffin, Audrey De Jong, Denis Frasca, Marc Garnier, Aurelie Gouel, Jérémie Jacques, Arthur James, Yoann Launey, Anne‐Marie Leroi, Chloé Melchior, Daphné Michelet, François Mion, Maxime Nguyen, Emmanuel Rineau, Amélie Rollé, Sabine Roman, Stéphanie Sigaut, Heithem Soliman, Fabien Wuestenberghs, Frank Zerbib, Guillaume Gourcerol, Charlotte Desprez   +29 more
wiley   +1 more source

Naloxone for Antagonism of Morphine-Induced Respiratory Depression

, 1973
David E. Longnecker, PETER A. GRAZIS, G. W. N. Eggers   +2 more
openalex   +1 more source

Mucoadhesive Drug Delivery Systems for Oral Chronic Inflammatory Mucosal Diseases. The Future is Already Present. A Systematic Review

Oral Diseases, EarlyView.
ABSTRACT Background Oral lichen planus (OLP) and recurrent aphthous stomatitis (RAS) are considered the most painful oral inflammatory diseases, with high global prevalence and significant impacts on patients' quality of life. In the last decades, researchers have been exploring mucoadhesive drug delivery systems (MDDS) to improve drugs safety and ...
M. E. Mauceri, M. Coppini, V. De Caro, G. Di Prima, R. Mauceri, V. Panzarella, G. Giuliana, G. Campisi   +7 more
wiley   +1 more source

Consideration of naloxone. [PDF]

, 2012
The ACMD has been considering the issue of naloxone availability and provision, as an intervention to prevent drug-related deaths, since 2009 and has previously written to the Medicines and Healthcare products Regulatory Agency (MHRA) concerning ...

core